LifeStance Health Group (NASDAQ:LFST) and Alignment Healthcare (NASDAQ:ALHC) Head-To-Head Comparison

Alignment Healthcare (NASDAQ:ALHC) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, profitability and risk.

Earnings & Valuation

This table compares Alignment Healthcare and LifeStance Health Group”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alignment Healthcare	$3.95 billion	0.44	-$720,000.00	$0.19	43.95
LifeStance Health Group	$1.42 billion	3.37	$9.66 million	$0.13	96.69

LifeStance Health Group has lower revenue, but higher earnings than Alignment Healthcare. Alignment Healthcare is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Alignment Healthcare and LifeStance Health Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alignment Healthcare	0.89%	20.02%	3.46%
LifeStance Health Group	3.19%	3.39%	2.33%

Institutional and Insider Ownership

86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Risk & Volatility

Alignment Healthcare has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and target prices for Alignment Healthcare and LifeStance Health Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alignment Healthcare	0	4	7	0	2.64
LifeStance Health Group	0	4	6	1	2.73

Alignment Healthcare currently has a consensus price target of $23.60, indicating a potential upside of 182.63%. LifeStance Health Group has a consensus price target of $12.88, indicating a potential upside of 2.43%. Given Alignment Healthcare’s higher possible upside, analysts clearly believe Alignment Healthcare is more favorable than LifeStance Health Group.

Summary

Alignment Healthcare beats LifeStance Health Group on 8 of the 15 factors compared between the two stocks.

About Alignment Healthcare

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

About LifeStance Health Group

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.